Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: Feasibility and safety

Shailendra Chopra, Gerald D. Dodd, Matthew P. Chanin, Kedar N Chintapalli

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

OBJECTIVE. This study was performed to assess the feasibility and safety of radiofrequency ablation of hepatic tumors adjacent to the gallbladder. MATERIALS AND METHODS. Of the 83 patients who underwent radiofrequency ablation of hepatic tumors at our institution between December 1997 and August 2000, we identified eight patients - four men and four women who were 42-85 years old (mean age, 67 years) - who had tumors adjacent to the gallbladder. All ablations were performed with curative intent. We reviewed the patients' preablation imaging, radiofrequency ablation parameters, and course after ablation. Follow-up ranged from 3 to 22 months (mean, 8 months). RESULTS. Six patients with colorectal carcinoma and two with hepatocellular carcinoma had a total of 14 tumors adjacent to the gallbladder. Of the 14 tumors, nine (64%) were metastases and five (36%) were hepatocellular carcinoma. Eleven tumors (79%) were located directly adjacent to the gallbladder and three (21%) were located within 1 cm of the gallbladder. Tumor size ranged from 0.9 to 4.5 cm (mean, 3.6 cm). The number of radiofrequency ablations performed on each tumor ranged between one and six (mean, three ablations). Right upper quadrant pain developed in the immediate postablation period (within 7 days after the ablation) in six patients (75%) and ranged in duration from 5 to 21 days (mean, 7 days). Fever developed in four patients (50%), with a mean duration of 5 days. Arthralgia and right shoulder pain developed in one patient (12%). No deaths were noted in the immediate period after ablation. Complete ablation of all tumors visible on CT was achieved in seven patients. Of these, one patient (14%) had local tumor recurrence after 11 months. CONCLUSION. Radiofrequency ablation of tumors adjacent to the gallbladder is feasible and appears to be safe. Self-limited morbidity after ablation is noted in most patients and is probably related to a mild iatrogenic cholecystitis.

Original languageEnglish (US)
Pages (from-to)697-701
Number of pages5
JournalAmerican Journal of Roentgenology
Volume180
Issue number3
StatePublished - Mar 1 2003

Fingerprint

Gallbladder
Safety
Liver
Neoplasms
Hepatocellular Carcinoma
Shoulder Pain
Cholecystitis
Arthralgia
Colorectal Neoplasms
Fever
Neoplasm Metastasis
Morbidity
Recurrence
Pain

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Chopra, S., Dodd, G. D., Chanin, M. P., & Chintapalli, K. N. (2003). Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: Feasibility and safety. American Journal of Roentgenology, 180(3), 697-701.

Radiofrequency ablation of hepatic tumors adjacent to the gallbladder : Feasibility and safety. / Chopra, Shailendra; Dodd, Gerald D.; Chanin, Matthew P.; Chintapalli, Kedar N.

In: American Journal of Roentgenology, Vol. 180, No. 3, 01.03.2003, p. 697-701.

Research output: Contribution to journalArticle

Chopra, S, Dodd, GD, Chanin, MP & Chintapalli, KN 2003, 'Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: Feasibility and safety', American Journal of Roentgenology, vol. 180, no. 3, pp. 697-701.
Chopra, Shailendra ; Dodd, Gerald D. ; Chanin, Matthew P. ; Chintapalli, Kedar N. / Radiofrequency ablation of hepatic tumors adjacent to the gallbladder : Feasibility and safety. In: American Journal of Roentgenology. 2003 ; Vol. 180, No. 3. pp. 697-701.
@article{e934d1dfe863475ca2ee8d06cab95b68,
title = "Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: Feasibility and safety",
abstract = "OBJECTIVE. This study was performed to assess the feasibility and safety of radiofrequency ablation of hepatic tumors adjacent to the gallbladder. MATERIALS AND METHODS. Of the 83 patients who underwent radiofrequency ablation of hepatic tumors at our institution between December 1997 and August 2000, we identified eight patients - four men and four women who were 42-85 years old (mean age, 67 years) - who had tumors adjacent to the gallbladder. All ablations were performed with curative intent. We reviewed the patients' preablation imaging, radiofrequency ablation parameters, and course after ablation. Follow-up ranged from 3 to 22 months (mean, 8 months). RESULTS. Six patients with colorectal carcinoma and two with hepatocellular carcinoma had a total of 14 tumors adjacent to the gallbladder. Of the 14 tumors, nine (64{\%}) were metastases and five (36{\%}) were hepatocellular carcinoma. Eleven tumors (79{\%}) were located directly adjacent to the gallbladder and three (21{\%}) were located within 1 cm of the gallbladder. Tumor size ranged from 0.9 to 4.5 cm (mean, 3.6 cm). The number of radiofrequency ablations performed on each tumor ranged between one and six (mean, three ablations). Right upper quadrant pain developed in the immediate postablation period (within 7 days after the ablation) in six patients (75{\%}) and ranged in duration from 5 to 21 days (mean, 7 days). Fever developed in four patients (50{\%}), with a mean duration of 5 days. Arthralgia and right shoulder pain developed in one patient (12{\%}). No deaths were noted in the immediate period after ablation. Complete ablation of all tumors visible on CT was achieved in seven patients. Of these, one patient (14{\%}) had local tumor recurrence after 11 months. CONCLUSION. Radiofrequency ablation of tumors adjacent to the gallbladder is feasible and appears to be safe. Self-limited morbidity after ablation is noted in most patients and is probably related to a mild iatrogenic cholecystitis.",
author = "Shailendra Chopra and Dodd, {Gerald D.} and Chanin, {Matthew P.} and Chintapalli, {Kedar N}",
year = "2003",
month = "3",
day = "1",
language = "English (US)",
volume = "180",
pages = "697--701",
journal = "AJR. American journal of roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "3",

}

TY - JOUR

T1 - Radiofrequency ablation of hepatic tumors adjacent to the gallbladder

T2 - Feasibility and safety

AU - Chopra, Shailendra

AU - Dodd, Gerald D.

AU - Chanin, Matthew P.

AU - Chintapalli, Kedar N

PY - 2003/3/1

Y1 - 2003/3/1

N2 - OBJECTIVE. This study was performed to assess the feasibility and safety of radiofrequency ablation of hepatic tumors adjacent to the gallbladder. MATERIALS AND METHODS. Of the 83 patients who underwent radiofrequency ablation of hepatic tumors at our institution between December 1997 and August 2000, we identified eight patients - four men and four women who were 42-85 years old (mean age, 67 years) - who had tumors adjacent to the gallbladder. All ablations were performed with curative intent. We reviewed the patients' preablation imaging, radiofrequency ablation parameters, and course after ablation. Follow-up ranged from 3 to 22 months (mean, 8 months). RESULTS. Six patients with colorectal carcinoma and two with hepatocellular carcinoma had a total of 14 tumors adjacent to the gallbladder. Of the 14 tumors, nine (64%) were metastases and five (36%) were hepatocellular carcinoma. Eleven tumors (79%) were located directly adjacent to the gallbladder and three (21%) were located within 1 cm of the gallbladder. Tumor size ranged from 0.9 to 4.5 cm (mean, 3.6 cm). The number of radiofrequency ablations performed on each tumor ranged between one and six (mean, three ablations). Right upper quadrant pain developed in the immediate postablation period (within 7 days after the ablation) in six patients (75%) and ranged in duration from 5 to 21 days (mean, 7 days). Fever developed in four patients (50%), with a mean duration of 5 days. Arthralgia and right shoulder pain developed in one patient (12%). No deaths were noted in the immediate period after ablation. Complete ablation of all tumors visible on CT was achieved in seven patients. Of these, one patient (14%) had local tumor recurrence after 11 months. CONCLUSION. Radiofrequency ablation of tumors adjacent to the gallbladder is feasible and appears to be safe. Self-limited morbidity after ablation is noted in most patients and is probably related to a mild iatrogenic cholecystitis.

AB - OBJECTIVE. This study was performed to assess the feasibility and safety of radiofrequency ablation of hepatic tumors adjacent to the gallbladder. MATERIALS AND METHODS. Of the 83 patients who underwent radiofrequency ablation of hepatic tumors at our institution between December 1997 and August 2000, we identified eight patients - four men and four women who were 42-85 years old (mean age, 67 years) - who had tumors adjacent to the gallbladder. All ablations were performed with curative intent. We reviewed the patients' preablation imaging, radiofrequency ablation parameters, and course after ablation. Follow-up ranged from 3 to 22 months (mean, 8 months). RESULTS. Six patients with colorectal carcinoma and two with hepatocellular carcinoma had a total of 14 tumors adjacent to the gallbladder. Of the 14 tumors, nine (64%) were metastases and five (36%) were hepatocellular carcinoma. Eleven tumors (79%) were located directly adjacent to the gallbladder and three (21%) were located within 1 cm of the gallbladder. Tumor size ranged from 0.9 to 4.5 cm (mean, 3.6 cm). The number of radiofrequency ablations performed on each tumor ranged between one and six (mean, three ablations). Right upper quadrant pain developed in the immediate postablation period (within 7 days after the ablation) in six patients (75%) and ranged in duration from 5 to 21 days (mean, 7 days). Fever developed in four patients (50%), with a mean duration of 5 days. Arthralgia and right shoulder pain developed in one patient (12%). No deaths were noted in the immediate period after ablation. Complete ablation of all tumors visible on CT was achieved in seven patients. Of these, one patient (14%) had local tumor recurrence after 11 months. CONCLUSION. Radiofrequency ablation of tumors adjacent to the gallbladder is feasible and appears to be safe. Self-limited morbidity after ablation is noted in most patients and is probably related to a mild iatrogenic cholecystitis.

UR - http://www.scopus.com/inward/record.url?scp=0037372132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037372132&partnerID=8YFLogxK

M3 - Article

C2 - 12591677

AN - SCOPUS:0037372132

VL - 180

SP - 697

EP - 701

JO - AJR. American journal of roentgenology

JF - AJR. American journal of roentgenology

SN - 0361-803X

IS - 3

ER -